Influence of psychosocial factors on adherence to antihypertensive drug therapy. Results from a Cardiovascular Health Program cohort followed in the Metropolitan Region of Santiago, Chile;Influencia de factores psicosociales en la adherencia al tratamiento farmacológico antihipertensivo. Resultados de una cohorte del Programa de Salud Cardiovascular de la Región Metropolitana, Chile

Revista Medica de Chile

Volumn 142, Issue 10, 2014, Pages 1245-1252

  Sandoval, Daniela ^a   Chacón, Javier ^a   Muñoz, Reinaldo ^a   Henríquez, Óscar ^a   Koch, Elard ^b   Romero, Tomás ^c  

^a UNIVERSITY OF CHILE   (Chile)

^b Instituto MELISA ^*  (Chile)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antihypertensive agents; Hypertension; Patient compliance; Primary health care

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; CHILE; COHORT ANALYSIS; FEMALE; HUMAN; HYPERTENSION; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; QUESTIONNAIRE; RISK FACTOR; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; URBAN POPULATION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CHILE; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; URBAN POPULATION;

EID: 84919385922     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872014001000003     Document Type: Article

References (38)

1. Sabate E. World Health Organization. Adherence to Long Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
2. Dunbar-Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM, Doswell WM. Adherence in chronic disease. Annu Rev Nursing Res 2000; 18: 48-90.
3. Krousel-Wood M, Joyce C, Holt E, Muntner P, Webber LS, Morisky DL, et al. Predictors of decline in medication adherence results from the cohort study of medication adherence among older adults. Hypertension 2011; 58: 804-10.
4. Waeber B, Burnier M, Brunner HR. How to improve adherence with prescribed treatment in hypertensive patients? J Cardiovasc Pharmacol 2000; 35 (3): S23-6.
5. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Bethesda, MD, National High Blood Pressure Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. 1997.
6. AlGurair S, Hughes C, Simpson S, Guirguis L. A systematic review of patient self-reported barriers of adherence to antihypertensive medication using the World Health Organization Multidimensional Adherence Model. J Clin Hypertens 2012; 14 (12): 877-86.
7. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336: 1114-7.
8. Morgan SG, Yan L. Persistence with hypertension treatment among community-dwelling BC seniors. Can J Clin Pharmacol 2004; 11: e267-73.
9. Ministerio de Salud, MINSAL. Encuesta Nacional de Salud, Chile, Vol. 1. Santiago, 2009-2010.
10. Garrido J, Chacón J, Sandoval D, Muñoz R, López N, Oyarzún E, et al. Control del Hipertenso, un desafío no resuelto: Avances logrados en Chile mediante el Programa de Salud Cardiovascular. Rev Chil Cardiol 2013; 32 (2): 85-96.
11. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24 (1): 67-74.
12. Pérez M, Leiva F, Martos F, Ruiz AJ, Prados D, Sánchez F. ¿Cómo diagnosticar el cumplimiento terapéutico en atención primaria? Medicina de Familia (And) 2000; 1: 13-19.
13. Rodríguez MA, García-Jiménez E, Amariles P, Rodríguez A, Faus MJ. Revisión de test de medición del cumplimiento terapéutico utilizados en la práctica clínica. Atención Primaria 2008; 40 (8): 413-7.
14. Bozzo G, Martínez B, Sepúlveda P, Carvacho C, Rivera G, Moore P, et al. Desarrollo y validación de una encuesta para la satisfacción de los pacientes con la consulta médica en consultorios de atención primaria. Rev Med Chile 1995; 123: 1160-4.
15. De la Revilla L, Luna J, Bailón E, Medina I. Validación del cuestionario MOS de apoyo social en atención primaria. Medicina de Familia (And) 2005; 6: 10-8.
16. Riquelme N, Merino J. Sistemas de enfrentamiento en familias de enfermos alcohólicos. Cienc Enferm 2002; 8: 37-47.
17. Garmendia ML, Alvarado ME, Montenegro M, Pino P. Importancia del apoyo social en la permanencia de la abstinencia del consumo de drogas. Rev Med Chile 2008; 136: 169-78.
18. Arias L, Herrera J. El APGAR familiar en el cuidado primario de salud. Colombia Médica 1994; 25 (1): 26-8.
19. Smilkstein G, Ashoworth D, Montano D. Validity and reliability of the family APGAR as a test of family function. J Fam Pract 1982; 15: 303-11.
20. Golberg DP, Hillier VF. A scale versión of the General Health Questionnaire. Psychological Medicine 1979; 9: 139-45.
21. Golberg D, Gater R, Sartorius N, Ustun T, Piccinelli M, Gureje O, et al. The validity of two versions of GHQ in the WHO study of mental illness in general health care. Phychol Med 1997; 27: 191-7.
22. Makowska Z, Merecz D, Moscicka A, Wojciech K. The validity of General Health Questionnaire, GHQ-12 and GHQ-28, in Mental Health studies working people. IJOMEH 2002; 15 (4): 353-62.
23. Subramanian V, Delgado I, Jadue L, Vega J, Kawachi I. Income inequality and health: multilevel analysis of chilean communities. J Epidemiol Community Health 2003; 57 (11): 844-8.
24. Idler E, Benyamini Y. Self-rated health and mortality: A review of 27 community studies. J Health Soc Behav 1997; 38 (1): 21-37.
25. Collins JC, Bentz JE. Behavioral and psychological factors in obesity. J Lancaster Gen Hosp 2009; 4 (4): 124-7.
26. Petrak F, Herpertz S, Albus C, Hirsch A, Kulzer B, Kruse J. Psychosocial factors and diabetes mellitus: evidencebased treatment guidelines. Curr Diab Rev 2005; 1: 255-70.
27. Macdonald H, Garg AX, Haynes RB. Interventions to enhance patients adherence to medication Prescriptions. Scientific Review. JAMA 2002; 288: 2868-79.
28. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002; (2): CD000011.
29. Wetzels GEC, Nelemans P, Schouten JS, Prins MH. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens 2004; 22: 1849-55.
30. Cramer JA. Microelectronic systems for monitoring and enhancing patient by compliance with medication regimens. Drugs 1995; 49: 321-7.
31. Bertholet N, Favrat B, Fallab-Stubi CL, Brunner HR, Burnier M. Why objective monitoring of compliance is important in the management of hypertension. J Clin Hypertens 2000; 2: 258-62.
32. Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 2001; 19: 335-41.
33. Nuesch R, Schroeder K, Dieterle T, Martina B, Battegay E. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ 2001; 323: 142-6.
34. Waeber B, Leonetti G, Kolloch R, McInnes GT. Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study. J Hypertens 1999; 17: 1041-5.
35. Mallion JM, Dutrey-Dupagne C, Vaur L, Genes N, Renault M, Elkik F, et al. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens 1996; 14: 137-44.
36. Rubin R, Mark Peyrot M, Saudek C. Effect of Diabetes Education on self-care, metabolic control, and emotional well-being. Diabetes Care 1989; 12: 673-9.
37. Sandoval D, Bravo M, Koch E, Gatica S, Ahlers I, Henríquez O, Romero T. Overcoming Barriers in the Management of Hypertension: The Experience of the Cardiovascular Health Program in Chilean Primary Health Care Centers. Int J Hypertens 2012; doi 10. 1155/2012/405892.
38. Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Díaz R, et al. Prospective Urban Rural Epidemiology (PURE) Study Investigators. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011; 378 (9798); 1231-43.